Gentamicin-Resistant Bacillary Infection
- 1 February 1978
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 138 (2) , 201-205
- https://doi.org/10.1001/archinte.1978.03630260015009
Abstract
Infections caused by gentamicin sulfate-resistant Pseudomonas aeruginosa and Serratia marcescens have occurred in multiple areas of our hospitals and have caused serious clinical illness and death. Isolates of Pseudomonas organisms were sensitive to some alternative drugs including colistin sulfate, but isolates of Serratia organisms were often resistant to all commercially available parenteral antimicrobials. All isolates were inhibited by amikacin sulfate, and 95% were killed by concentrations achievable in serum with recommended doses. Twenty patients with hospital-acquired infections, including ten with septicemia, were treated with amikacin. Eighteen of the 20 patients had a good clinical and bacteriologic response. Ototoxicity and nephrotoxicity each occurred in one patient. (Arch Intern Med 138:201-205, 1978)This publication has 6 references indexed in Scilit:
- Ototoxicity of AmikacinAntimicrobial Agents and Chemotherapy, 1976
- Sulfamethoxazole-Trimethoprim-Polymyxin Therapy of Serious Multiply Drug-Resistant Serratia InfectionsAntimicrobial Agents and Chemotherapy, 1976
- In Vitro Studies of BB-K8, a New Aminoglycoside AntibioticAntimicrobial Agents and Chemotherapy, 1973
- Simplified Assay for Gentamicin in the Presence of Other AntibioticsAntimicrobial Agents and Chemotherapy, 1973
- Comparative Pharmacokinetics of BB-K8 and Kanamycin in Dogs and HumansAntimicrobial Agents and Chemotherapy, 1973
- THE EVOLUTION AND SPREAD OF GENTAMICIN-RESISTANT PSEUDOMONADSPublished by Wolters Kluwer Health ,1971